Study guide

8.3 Controlled Prescriptions and the EPCS Mandate

Connecticut Multistate Pharmacy Jurisprudence Examination CT MPJE

Track your progress as you read

Finished sections get a check mark.

1 Introduction & Exam Overview

1.1 About the Connecticut MPJE 1.2 Application, Fees, ATT, and Pearson VUE 1.3 Blueprint, Scoring, Retakes, and Study Strategy

2 Connecticut Regulatory Structure

2.1 DCP and the Commission of Pharmacy 2.2 Chapter 400j, 420b/420c, and RCSA 20-576 2.3 Federal vs Connecticut Law (More Restrictive Rule)

3 Pharmacist Licensure, Interns, PIC, and CE

3.1 Pharmacist Qualifications and Exam Path 3.2 Interns, Score Transfer, and Reciprocity 3.3 Pharmacist-in-Charge / Pharmacist Manager 3.4 License Renewal and Continuing Education

4 Technicians and Non-Pharmacist Personnel

4.1 Technician Registration and Certification 4.2 Community Technician Ratios (20-576-36) 4.3 Institutional Ratios and Advanced Pharmacy Technicians 4.4 Technician Limitations, Interns, and Unlicensed Staff

5 Discipline, Impairment, and Unlicensed Practice

5.1 Disciplinary Grounds (CGS § 20-579) 5.2 Impaired Practitioner Reporting and Programs 5.3 Unlicensed Practice, Penalties, and Appeals

6 Federal Drug Law Foundations

6.1 FDCA, Adulteration, and Misbranding 6.2 FDA Approval, Recalls, and OTC vs Rx 6.3 DSCSA, HIPAA, OBRA ’90, and PPPA

7 Federal Controlled Substances

7.1 CSA Schedules and Definitions 7.2 DEA Registration and Forms 222, 106, 41 7.3 Federal Controlled-Substance Prescription Rules 7.4 Inventory, Theft, Loss, and Disposal

8 Prescription Issuance in Connecticut

8.1 Who May Prescribe in Connecticut 8.2 Noncontrolled Prescription Form and Content 8.3 Controlled Prescriptions and the EPCS Mandate

9 Refills, Partial Fills, and Opioid Limits

9.1 Refill Authority (Noncontrolled and CIII–V) 9.2 Partial Fills of Schedule II Prescriptions 9.3 Connecticut Opioid Supply Limits (7-day / 5-day)

10 Administration, CDTM, and Standing Orders

10.1 Pharmacist Immunization Authority 10.2 Collaborative Drug Therapy Management 10.3 Naloxone and Opioid Antagonist Access 10.4 Emergency and Hormonal Contraception

11 Counseling, Confidentiality, and Returns

11.1 Counseling and Offer to Counsel 11.2 HIPAA and Connecticut Confidentiality 11.3 Return, Reuse, and Take-Back

12 Corresponding Responsibility and DUR

12.1 Corresponding Responsibility and Legitimate Medical Purpose 12.2 Prospective Drug Utilization Review 12.3 Exceptions and Conditions Prohibiting Dispensing

13 Transfers, Labeling, Packaging, and Delivery

13.1 Transferring Prescriptions 13.2 Labeling of Dispensed Drugs 13.3 Packaging and the Poison Prevention Packaging Act 13.4 Delivery of Drugs

14 CPMRS, Substitution, and Nonprescription Drugs

14.1 CPMRS Query and Reporting 14.2 Generic and Biosimilar Substitution 14.3 CMEA and Behind-the-Counter Products 14.4 OTC Labeling, Hazardous, and Restricted Nonprescription Drugs

15 Ordering, Records, and Inventories

15.1 Ordering and Acquisition (DEA 222/CSOS) 15.2 Distribution and DSCSA Records 15.3 Recordkeeping Content and Three-Year Retention 15.4 Controlled-Substance Inventories and CT Perpetual CII

16 Storage, Security, and Hazardous Drugs

16.1 Controlled-Substance Storage and Security 16.2 Hazardous Drugs (USP <800>, NIOSH) 16.3 Non-Pharmacist Access to Drugs

17 Compounding and Central Fill

17.1 Nonsterile Compounding (USP <795>, RCSA 20-576-69) 17.2 Sterile Compounding (USP <797>, RCSA 20-576-64) 17.3 Central Fill, 503A, and 503B Outsourcing

18 Pharmacy Permits and Practice Settings

18.1 Pharmacy License, Hours, Manager, and Signage 18.2 Nonresident, Hospital, Nuclear, and Automated Dispensing 18.3 Inspection, Closure, and Facility Discipline

8.3 Controlled Prescriptions and the EPCS Mandate

Key Takeaways Explain This Topic AI

CGS § 21a-249(a) requires CS prescriptions to include patient name and address (or animal owner and species), whether the patient is an adult or a child or the specific age, the drug and amount, directions, prescriber name and address, date of issuance, and the practitioner's DEA number.

A Schedule II prescription blank may contain only one prescription; previously signed paper CII orders are not valid CIIs once EPCS is required at issuance (CGS § 21a-249(a), (e)).

Connecticut requires EPCS for controlled substances (CGS § 21a-249(b), effective January 1, 2018) with statutory exceptions in § 21a-249(c), including temporary technology failure, a documented 5-day-supply delay exception, out-of-state pharmacy, specified negative-impact-on-care situations, and demonstrated lack of technological capacity (not available to telehealth providers).

Emergency oral Schedule II orders require a covering prescription prepared by the prescriber to be mailed or delivered within 72 hours — stricter than the federal seven-day covering rule (CGS § 21a-249(e)).

Each pharmacy must accept an electronically transmitted controlled-substance prescription (CGS § 21a-249(n)); CS records are kept three years.

Last updated: August 2026

Why Connecticut controlled-substance issuance is stricter than the CSA floor

Quick Answer: CGS § 21a-249 is the Connecticut CS prescription statute. Every CS prescription must include patient name and address (or owner and species ), adult or child or specific age , drug and amount , directions , prescriber name and address , date , and DEA number . EPCS is required at issuance for DCP-authorized prescribers ( § 21a-249(b) ; Public Act 17-131, January 1, 2018 ), with the § 21a-249(c) exceptions. Pharmacies shall accept EPCS ( § 21a-249(n) ). Emergency oral CII covering prescriptions are due in 72 hours , not the federal 7 days . Previously signed paper CII orders are not valid CIIs when electronic issuance is required ( § 21a-249(e) ). CT may be stricter; more-restrictive wins.

NABP Competency 2.1.4 is controlled-substance issuance. Chapter 7 taught the federal CSA. This section is the Connecticut overlay. When the two differ, use the tighter rule. The 72-hour covering prescription is the highest-yield example on this exam.

Required CS elements — more than § 20-614

CGS § 21a-249(a) requires all prescriptions for controlled drugs to include:

  • The name and address of the patient , or the name and address of the owner of an animal and the species
  • Whether the patient is an adult or a child , or the patient's specific age
  • The compound or preparation prescribed and the amount
  • Directions for use
  • The name and address of the prescribing practitioner
  • The date of issuance
  • The Federal Registry number of the practitioner (the DEA number)

Adult or child, or specific age , is a Connecticut add-on many candidates forget because it is not a federal 21 CFR § 1306.05 headline. A CII that names the patient and address but is silent on adult/child/age is incomplete under § 21a-249(a)(2).

The same subsection adds two validity rules. No prescription blank containing a prescription for a Schedule II substance shall contain more than one prescription. No prescription or order for a controlled substance issued to an inanimate object or thing is valid. A CII written for “the office crash cart” or “the ambulance kit” as if the kit were the patient is not a prescription under Chapter 420b.

CGS § 21a-249(d) allows, only when an exception in subsection (c) applies , a CS prescription as a written order or, to the extent the federal CSA allows , an oral order or a fax . The pharmacist filling an oral or fax order shall promptly reduce it to writing on a prescription blank, a hardcopy printout, or an electronic record. No duplicate, carbon, or photographic copies and no printed or rubber-stamped orders are valid CS prescriptions under this chapter.

CGS § 21a-249(f) requires full compliance with additional federal FDCA, CSA, and Connecticut Chapter 420b requirements. Federal CII no-refill and CIII–IV five refills / six months (repeated in § 21a-249(h)) remain. Refill math is Chapter 9 .

The EPCS mandate and its exceptions

CGS § 21a-249(b) requires each § 20-14c prescribing practitioner whom DCP authorizes to prescribe controlled substances, within that license's scope, to electronically transmit the CS prescription to a pharmacy. Electronic prescriptions must be consistent with the federal CSA . The prescriber shall promptly print a hard copy or create an electronic record and file it; those prescriber records are kept three years on the licensed practitioner's premises, readily available for inspection. “Electronically transmit” means transmission by computer modem or similar electronic device.

DCP's EPCS page (current April 2025) traces the mandate to Public Act 17-131 , Section 3, starting January 1, 2018 , for all controlled substances . Pharmacists can verify a prescriber's waiver / exemption status in real time on elicense.ct.gov . Do not guess from a paper blank that “everyone still writes these.”

CGS § 21a-249(c) is the exception list. A licensed practitioner is not required to electronically transmit when:

Exception What the statute actually requires

(1) Temporary technological or electrical failure Computer, application, device, or power/service interruption that reasonably prevents use of the certified EPCS application. The practitioner shall without undue delay reasonably attempt to correct causes within the practitioner's control, and shall document the reason in the patient's medical record as soon as practicable, not more than 72 hours after the failure ends .

(2) Delay would harm the patient The practitioner reasonably determines it would be impractical for the patient to obtain an electronically transmitted prescription in a timely manner and that delay would adversely impact the medical condition. If the drug is a controlled substance, the quantity may not exceed a 5-day supply if used as directed. Document the reason in the medical record.

(3) Pharmacy located outside Connecticut Document the reason in the medical record. This is the lawful path for a Connecticut writer sending paper or other non-electronic CS to an out-of-state pharmacy — the reverse of the incoming out-of-state fill in section 8.1.

(4) Electronic transmission may negatively impact care Examples in the statute: two or more products to be compounded ; a prescription for direct administration by parenteral, IV, IM, subcutaneous, or intraspinal infusion ; long or complicated directions ; elements the FDA requires on the prescription; or an oral prescription communicated to a pharmacist for a patient in a chronic and convalescent nursing home .

(5) No technological capacity The practitioner demonstrates, in a form and manner the commissioner prescribes, that the practitioner lacks a computer system, hardware, or device that can electronically transmit CS prescriptions consistent with the CSA. This subdivision does not apply when the practitioner is prescribing as a telehealth provider under CGS § 19a-906(c).

CGS § 21a-249(e) then special-rules Schedule II: CII prescriptions shall be electronically transmitted by the prescribing practitioner at the time of issuance , and previously signed orders for such Schedule II substances shall not be considered valid prescriptions within the meaning of Chapter 420b. A pad of pre-signed CII blanks in the office drawer is not a legal inventory. A “post-dated signed CII we keep until the patient needs it” is not a valid Connecticut CII once EPCS is the issuance method.

CGS § 21a-249(n) closes the pharmacy-side loophole: each pharmacy shall accept an electronically transmitted CS prescription from a practitioner (as defined in CGS § 21a-316). Pharmacy CS records are kept three years at the pharmacy premises, current and separate from other business records, readily available for inspection. A store that “doesn't do electronic CII yet” is not in compliance.

Prescribers still file CS prescriptions separately (CII in one file or electronic file; CIII–V in another), chronologically and consecutively for written CS, under § 21a-249(k). That is a filing rule, not a reason to refuse EPCS.

Emergency oral CII — 72 hours, not seven days

To the extent the federal CSA permits, in an emergency the dispensing of Schedule II substances may be made upon the oral order of a prescribing registrant known to or confirmed by the filling pharmacist. CGS § 21a-249(e) then tightens the covering prescription: the filling pharmacist shall promptly reduce the oral order to writing, and the oral order shall be confirmed by the proper completion and mailing or delivery of a prescription prepared by the prescribing registrant to the pharmacist within seventy-two hours after the oral order has been given. That covering prescription is affixed to the temporary pharmacy-prepared prescription, and both are maintained on file.

Federal 21 CFR § 1306.11(d) gives the prescriber seven days to deliver the covering CII. Connecticut is 72 hours. On a Connecticut MPJE item, 72 hours is the number. If the covering prescription never arrives, treat it as an incomplete emergency CII and follow Drug Control / corresponding-responsibility practice — do not quietly convert the oral order into a refillable CIII.

The same subsection still forbids prescribing, dispensing, or administering Schedule II sympathomimetic amines as anorectics except as DPH and DCP jointly authorize by regulation. A pharmacist is not required to determine the patient's diagnosis before dispensing those substances when they are otherwise lawful.

Telehealth plus EPCS. Allowed CII/III telehealth prescribing under § 19a-906(c) (MAT or psychiatric disability / SUD, Ryan Haight-consistent, as amended June 30, 2025 ) must be electronically submitted under § 21a-249. The “no technological capacity” waiver does not shelter a telehealth provider. A Zoom visit that ends with a paper CII for buprenorphine because “the laptop was not certified” is the wrong exception.

Dual numbers on a new CS writer, and realistic scenarios

When a new Connecticut prescriber's first CII hits the queue, confirm DEA (on the order, § 21a-249(a)(7)) and CSP plus CPMRS registration (CGS § 21a-317) and professional license and scope . DCP's elicense lookup is also how you see an EPCS waiver . Out-of-state writers follow section 8.1: DCP still allows a valid out-of-state written or electronic CS if issuance requirements are met; that is not permission to skip DEA, quantity, or corresponding responsibility.

A Stamford emergency physician calls in an oral hydromorphone CII on Saturday for a discharged trauma patient. The pharmacist knows the physician, reduces the oral order to writing, and dispenses a quantity limited to the emergency. The physician's covering EPCS or paper prescription, as the exception allows, must be mailed or delivered within 72 hours , then affixed to the pharmacy's temporary Rx. Waiting until the following Saturday because “DEA allows seven days” fails § 21a-249(e) .

A West Hartford internist hands a patient a pre-signed paper CII for Adderall “because our EPCS module is down this afternoon,” without documenting a temporary technological failure or any other § 21a-249(c) exception. § 21a-249(e) says CII shall be electronically transmitted at issuance and previously signed paper orders are not valid CIIs . Do not fill it as a routine CII. If a true exception applies, the writer must use a permitted non-electronic method and document the reason — not a drawer of wet-ink blanks.

A compounding pharmacy receives a CS prescription for two bulk powders to be combined for an individual patient. § 21a-249(c)(4) is the negative-impact exception that expressly includes two or more products to be compounded. That is not a general “compounding shops are exempt from EPCS forever” rule; it is a listed reason a particular order may be non-electronic.

A community pharmacy manager instructs staff to reject all electronic CII because the printer is slow. § 21a-249(n) requires the pharmacy to accept electronically transmitted CS prescriptions. Fix the printer; do not invent a store policy that overrides the statute. CS records remain three years and separate .

Opioid 7-day / 5-day first-fill supply limits and CPMRS query triggers are Chapters 9 and 14 . They sit on top of this issuance chapter. A perfect EPCS oxycodone can still be the wrong day's supply.

Official anchors

CGS § 21a-249 (2025) — CS elements, EPCS mandate, exceptions, 72-hour emergency covering CII, pharmacy duty to accept EPCS.

DCP EPCS — P.A. 17-131, January 1, 2018 start, waiver lookup.

DCP out-of-state CS FAQ — written or electronic out-of-state CS if issuance requirements are met.

DCP prescribing-practice page (April 28, 2025) — 2017 EPCS requirement among the CS practice highlights.